Neuro-oncology
Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
Neuro-oncology
IMMU-52. SELECTION OF GLIOMA T-CELL THERAPY TARGETS BASED ON THE ANALYSIS OF TUMOR IMMUNOPEPTIDOME AND EXPRESSION PROFILES.
Neuro-oncology
Canine spontaneous glioma: a translational model system for convection-enhanced delivery.
Neuro-oncology
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Neuro-oncology
Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.
Neuro-oncology
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.
Neuro-oncology
TMIC-43. HEDGEHOG LIGANDS FROM GLIOBLASTOMA CELLS INDUCE ASTROCYTES INHIBITION OF CANCER STEM CELLS.
Neuro-oncology
Temozolomide-associated hypermutation in gliomas.
Neuro-oncology